Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1978-2-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0007-0963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
505-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:145236-Atrophy,
pubmed-meshheading:145236-Betamethasone,
pubmed-meshheading:145236-Betamethasone 17-Valerate,
pubmed-meshheading:145236-Fibroblasts,
pubmed-meshheading:145236-Glycosaminoglycans,
pubmed-meshheading:145236-Humans,
pubmed-meshheading:145236-Hydrocortisone,
pubmed-meshheading:145236-Skin
|
pubmed:year |
1977
|
pubmed:articleTitle |
Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone 17-butyrate and betamethasone 17-valerate.
|
pubmed:publicationType |
Journal Article
|